| C0032181 |
Platelet Count measurement |
EFO |
platelet count
|
0004309 |
| C0032181 |
Platelet Count measurement |
MSH |
Blood Platelet Count
|
D010976 |
| C0032181 |
Platelet Count measurement |
MSH |
Platelet Count
|
D010976 |
| C0032181 |
Platelet Count measurement |
NCI |
Platelet Count
|
C51951 |
| C0032181 |
Platelet Count measurement |
NCI |
Anucleated Thrombocytes
|
C51951 |
| C0032181 |
Platelet Count measurement |
NCI |
Adenocarcinoma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Primary Myelofibrosis
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Alcohol Consumption
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Refractory Anemia
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Rheumatoid Arthritis
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Ascites
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Asthma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Astrocytoma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Barrett Esophagus
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Brain Neoplasm
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Burkitt Lymphoma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Malignant Neoplasm
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Carcinoid Tumor
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Carcinoma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Prostate Adenocarcinoma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Mucinous Adenocarcinoma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Papillary Carcinoma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Renal Cell Carcinoma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Squamous Cell Carcinoma
|
TCGA |
| C0032181 |
Platelet Count measurement |
NCI |
Cervical Neoplasm
|
TCGA |